Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
“So nice to meet with the NCI Director Dr. Letai.
We need an all‑hands‑on‑deck approach from everyone to beat cancer. These are the best times in oncology research – we’re finally going after the “undruggable,” targets and it’s incredible to have NCI Cancer Trials NCI Media, NIH in the mission to cure cancer.”
Other articles featuring Vivek Subbiah on OncoDaily.